Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

47.02 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Twist Bioscience Corp

< Previous 1 2 3 4 5 6 7 8 Next >
Twist Bioscience Collaborates with Deep Learning Experts deepCDR on Antibody Library Design
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
From Twist Bioscience Corporation and Adicet Bio
Via Business Wire
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Baird 2021 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Acquires NGS Library Preparation Maker iGenomX
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital
From Twist Bioscience Corporation
Via Business Wire
DNA Data Storage Alliance Publishes First White Paper, Launches Website
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Upcoming Virtual Conferences
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Supports the Engineering Biology Research Consortium as it Publishes Statement of Ethics
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Report Fiscal 2021 Second Quarter Financial Results on Thursday, May 6, 2021
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Expand Oregon Lease, Supporting Future Growth
From Twist Bioscience Corporation
Via Business Wire
Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Exercises Option to Purchase Custom Designed Antibody Library and Optimization Software
From Twist Bioscience
Via Business Wire
AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.